Alphatec Holdings Inc (Alphatec), is a medical technology company that designs, develops, manufactures and markets spinal fusion technology solutions and products for the treatment of spinal disorders associated with trauma, disease and degeneration, and congenital deformities.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company’s R&D focuses on developing technology platforms and products for degenerative and deformity spine pathologies. It collaborated with surgeon partners to design products that enhance the surgeon experience, reduce overall costs, improve patient outcomes and simplify surgical techniques. Its resources include a cadaveric lab, mechanical testing laboratory and technology advancement cell for rapid prototyping. In FY2022, the company spent US$44 million on its R&D activities, which as a percentage of revenue stood at 12.5%, and grew 37.5% YoY.